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ABSTRACT

During differentiation stem cells are exposed to a range of microenvironmental chemical and
physical cues. In this study, human multipotent progenitor cells (hMLPCs) were differentiated
from umbilical cord into oligodendrocytes and astrocytes. Chemical cues were represented by a
novel defined differentiation medium containing the neurotransmitter norepinephrine (NE). In
traditional 2 dimensional (2D) conditions, the hMLPCs differentiated into oligodendrocyte
precursors, but did not progress further. However, in a constructed 3 dimensional (3D)
environment, the hMLPCs differentiated into committed oligodendrocytes that expressed MBP.
When co-cultured with rat embryonic hippocampal neurons (EHNs), hMLPCs developed in
astrocytes or oligodendrocytes, based on presence of growth factors in the differentiation
medium. In co-culture, physical cues provided by axons were essential for complete
differentiation of both astrocytes and oligodendrocytes. This study presents a novel method of
obtaining glia from human MLPCs that could eliminate many of the difficulties associated with
their differentiation from embryonic stem cells. In addition, it reveals the complex interplay
between physical cues and biomolecules on stem cell differentiation.
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1. INTRODUCTION AND REVIEW OF THE LITERATURE

1.1. Oligodendrocytes: Historical Overview
Oligodendrocytes are glial cells in central nervous system (CNS). They were the last glial cells
discovered at the beginning of the 20th century. These cells were resistant to classical metal
impregnations used for staining cells. However, a new staining method created by Pio del Rio
Hortega led him to visualize these cells in 1921. He introduced the word "oligodendrocyte" from
the Greek -oligo- for few, -dendro- for tree, and -cyte- for cell, to describe a cell with fewer
processes than the other cells. Oligodendrocytes make and maintain CNS myelin, the protective
sheath around axons, referred to as white matter1. The myelin sheath is a lipid rich membrane
formed by modified extensions of oligodendroglial cell processes, wrapped in a spiral fashion
around an axon2. The word myelin originates from Greek myelos, meaning marrow. Myelin was
named and described in 1858 by the German pathologist Rudolf Virchow because of its
resemblance to marrow, long before its function or its composition was known. Each
oligodendrocyte is able to myelinate as many as 50 different axons2. The sections of myelin are
separated from each other by small segments in which the bare axon is exposed to the interstitial
space. These segments are called nodes of Ranvier, after the French histologist Louis-Antoine
Ranvier who described them for the first time in 1878. Nodes of Ranvier are the location of
multiple sodium channels. Along unmyelinated fibers, action potential moves continuously.
However, when the axon is myelinated, the electrical impulse cannot flow through the highresistance myelin sheath and therefore flows out through from one node of Ranvier to the next
1

node with little energy and increased speed. The non-linear and rapid conduction of electrical
impulses is called saltatory conduction, because the action potential jumps from node to node3-5.

Figure 1. Oligodendrocytes.
Fluorescent light micrograph of oligodendrocytes from a mouse. The mouse had been genetically
engineered to express green fluorescent protein (GFP) in its oligodendrocytes.

Figure 2. Electron Micrograph Image. Branched Oligodendrocytes with Processes Extending to
Underlying Axons (http://www.regenecell.com).
2

1.2. Astrocytes: Rising Stars

Astrocytes are star-shaped glial cells. They are the most numerous cell type within the central
nervous system (CNS), first identified at the 19th century by Von Lenhossek6. Until recently,
astrocytes have been considered to be uninteresting „brain glue‟, providing an inert scaffold and
nutritional support necessary for neuronal distribution and interactions7. Recent findings suggest
many new functions for these cells and highlight the importance of viewing most brain activities
as collaboration between astrocytes and neurons. Astrocytes have been implicated in
maintenance of the blood-brain barrier, dynamic regulation of neuron production, synaptic
network formation and neuron electrical activity and in specific neurological diseases. This
multi-functionality may explain the multiplicity of astrocyte subtypes found throughout the CNS.
The human CNS has the highest numbers of glia, the greatest glia-neuron ratio8-10, and the
greatest heterogeneity of glial cells11 compared with other animal species. The broad category of
astrocytes is subdivided into fibrous or protoplasmic subtypes, based on their morphology,
antigen binding and localization to white or gray matter 12. Fibrous astrocytes have many glial
filaments and are located mainly in white matter; protoplasmic astrocytes have fewer glial
filaments and are found mainly in gray matter12, 13. Whereas fibrous astrocytes tend to have
regular contours and to extend cylindrical branching processes, protoplasmic astrocytes have
irregular contours and extend sheet-like processes. Fibrous and protoplasmic astrocytes were
suggested to be biochemically and developmentally distinct and correspond to the type-1 and
type-2 astrocytes, originally defined in cultures of developing rat optic nerve12, 14.

3

Figure 3. Glia-neuron interaction.
Different types of glia interact with neurons and the surrounding blood vessels.
Oligodendrocytes wrap myelin around axons to speed up neuronal transmission. Astrocytes
extend processes that ensheath blood vessels and synapses. Microglia keep the brain under
surveillance for damage or infection15.
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1.3. Development of Oligodendrocytes and Astrocytes
Oligodendrocytes and astrocytes arise from neuroepithelial stem cells early during development
of brain and spinal cord. Neuroepithelial stem cells proliferate and give rise first to motoneuron
and later to glial progenitor cells16-19. Some findings provide evidence that a common glial
progenitor cell gives rise to both oligodendrocytes and astrocytes20-22. Other findings suggest that
oligodendrocytes either derive independently or derive from common motoneuron and
oligodendrocyte precursors23,

24

. The most recent studies support a sequential model of

differentiation (Figure3). In this model, motoneurons, oligodendrocytes and astrocytes arise
sequentially from sequentially derived precursors25.

Figure 4. Sequential Model.
The sequential model explains how neuroepithelial stem cells (NSC) might generate
motoneurons (MN), oligodendrocytes (O) and astrocytes (Ast) (pM, motoneuron precursor;
OPC, oligodendroctye precursor; pA, astrocyte precursor). NSCs at different stages in the
sequential model are coded in different colors to reflect restrictions in competence 25.
5

The precursors are found in close contact with the surrounding environment that serves as a
source of many chemical and biophysical signals. The signals from other cells and the
extracellular environment are then integrated with the intracellular forces to control proper and
timely differentiation26. The early steps of differentiation can sometimes be reversed or altered
when specific microenvironmental signals are absent or overridden27. For example, bi-potential
glial progenitor cells were shown to develop in vitro into a specific astrocyte population (the
type-2 astrocyte) if cultured in presence of serum or into oligodendrocytes if cultured in the
absence of serum28. In certain culture conditions some of these cells acquire a mixed phenotype,
displaying properties of both astrocytes and oligodendrocytes, or revert back to stem cell like
cells. Due to its potential, the single glial progenitor cell is alternatively called an
oligodendrocyte type-2 astrocyte (O2A) progenitor or an oligodendrocyte precursor cell (OPC)29.
O2As can be immunostained with the monoclonal antibody A2B5, which detects gangliosides on
the surface of the cells30.
The progression of the oligodendroglial linage is characterized by dramatic morphological
changes and the acquisition of specific surface antigens. The oligodendrocyte progenitors can be
detected with the A2B5 antibody. Precursors express the O4 sulfatide, which persists in ramified
but yet immature oligodendrocytes. Committed oligodendrocytes lose A2B5 reactivity after they
begin to express O1 galactocerebroside. Differentiated oligodendrocytes, which are post-mitotic
and richly multipolar cells, when mature, express myelin proteins such as myelin basic protein
(MBP), and gradually initiate the process of myelination30-33.
Developing type-2 astrocytes exhibit radial processes and also express the gangliosides detected
with the A2B5 antibody at early stages of differentiation. However, they are distinguished from

6

O2As by their expression of the astrocyte marker, glial fibrillary acidic protein (GFAP). As
astrocytes mature, their GFAP expression remains, while A2B5 immunoreactivity diminishes.
The type-2 astrocytes can be found in white but mainly in gray matter throughout the CNS 12, 14.
They were observed in tracts of myelinated axons and there is evidence that processes from type2 astrocytes contribute to the structure of nodes of Ranvier. They have been also shown to
promote myelination in response to electrical impulses34. It has been suggested that the O2A
lineage is involved in construction of myelin sheaths and nodes in the mammalian CNS 35.

7

Figure 5. Diagram Depicting the Differentiation of the O2A Lineage.
The differentiation of oligodendrocytes from their progenitors follows a morphological
transformation from a GD3 positive spherical stem cell to the A2B5 and nestin positive
bipotential O2A precursor cell. When cultured in the presence of defined medium, the O2A
precursors becomes a prooligodendrocyte, which is multipolar, has short processes, and exhibits
immunoreactivity with the O4 antibody. The prooligodendrocyte differentiates into the
galactocerebroside (GC or O1 antigen) positive oligodendrocyte. When the O2A precursor is
cultured in the presence of serum, it differentiates into the A2B51 type 2 astrocyte, expressing
GFAP. Type 2 astrocytes exhibit a stellate morphology30.

8

1.4. Effect of Noradrenergic Signaling on Oligodendrocyte and Astrocyte Differentiation
Differentiation of oligodendrocytes and astrocytes in the local tissue environment depends
closely on the gradients of soluble factors and physical cues activating distinct signaling
pathways. The development to an oligodendrocytes phenotype is controlled by distinct molecular
mechanisms. The soluble factors involve platelet-derived growth factor-AA (PDGF-AA), basic
fibroblast growth factor (bFGF), epidermal growth factor (EGF) and changes in intracellular
cyclic adenosine monophosphate (cAMP) levels. Another soluble factor involved in
differentiation is norepinephrine (NE)36-39. NE is a small molecule catecholamine with a dual
role as a hormone and a neurotransmitter. As a hormone, it is secreted by the adrenal gland and
along with epinephrine it affects the fight or flight response during times of stress. As a
neurotransmitter it is released from noradrenergic neurons and modulates emotions, learning and
memory40-42. NE has been shown to be involved in the development and functional maturation of
spinal cord43. The noradrenergic nerve terminals can be visualized in the ventral horn at birth,
with a pattern similar to that of the adult, and regulate development of spinal motoneurons43-45.
Previous studies demonstrated a function of NE in the neuronal differentiation of cells that
express adrenergic receptors (ARs)46, 47. The effect of NE on oligodendrocyte differentiation is
not well understood. However, it was revealed that noradrenergic fibers contact oligodendrocytes
at sites that resemble symmetrical synapses, suggesting that oligodendrocytes are NE‟s primary
target48. NE binds to and activates  and - ARs. Oligodendrocytes express both -1 and ARs37,

49-51

. It has also been shown that activation of -1 adrenergic signaling influenced

formation of processes and production of myelin. NE increases activity of protein kinase C
(PKC), p38 mitogen-activated protein kinases (MAPK) and phosphoinositide (PI) hydrolysis49, 50,
9

52, 53

. Alternatively, activation of -adrenergic signaling by NE inhibits proliferation and

accelerated linage progression. The biological effect of NE is mediated through an increase in
intracellular cAMP, activity of ERK (extracellular signal-regulated kinase) and of proteins
essential for the cell cycle arrest. It was suggested that -AR-mediated signaling may be
restricted to proliferative phases of oligodendrocyte development, and dismantled after
proliferation arrest 37, 54, 55.

4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol

(C8 H11 N O3)

Figure 6. Molecular Structure of Norepinephrine.
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Figure 7. Schematic Representation of the Cortical Noradrenergic Afferents with Neuronal,
Vascular and Glial Elements.
Pyramidal and non-pyramidal neurons have been shown to have noradrenergic synapses and
astrocytes and oligodendrocytes are engaged in discrete anatomical relationships with
noradrenergic boutons and fibers (As, astrocyte; ASP, astroglial processes; B, basal lamina; Cap,
capillary; End, endothelial cell; NA, noradrenaline; n-Pyr, non-pyramidal neuron; 0,
oligodendrocyte; P, pericyte; Pyr, pyramidal neuron; zo, zonula occludens 48).

Figure 8. Electron Micrographs of Oligodendroglial Perikarya.
Arrowheads indicate thickening of the oligodendrocyte membrane at the site of contact with
noradrenergic boutons48.
11

Figure 9. Norepinephrine Acts on its Target Cells by Binding to and Activating Alpha and BetaAdrenergic Receptors (ARs).
The beta-adrenergic receptor (ßAR) may couple either through Gi or Gs to adenylcyclase in an
inhibitory or stimulatory fashion, resulting in an increased formation of cyclic AMP and
activation of protein kinase A (PKA). Activation of alpha adrenergic receptor results in
activation of PLC. PLC cleaves phosphoinositol diphosphate (PIP2) into diacylglycerol (DAG)
and inositol triphosphate (IP3). DAG activates PKC, with IP3 causing an increase in (Ca2)i and
other agonists, each through their own independent receptors, which can activate protein kinase
C (PKC)56.
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1.5. Effect of Physical Cues on Differentiation
The physical cues that modify differentiation are defined by mechanical forces and discrete local
architecture57, 58. These conserved and evolutionary ancient features, although largely unknown,
are the source of many signals. The signals are transduced to the cell nucleus through changes in
cytoskeleton and complex signaling pathways. For example, it was shown that the fate decision
of the oligodendrocyte precursors is controlled by both the spatial and geometric characteristics
of an axonal niche. The critical cell density along an axon provides a mechanical stimulus
promoting differentiation, possibly through alteration of the size or shape of the cells59. Another
example presented studies with mesenchymal stem cells (MSCs), where it was demonstrated that
the size of the substrate pattern regulated cell shape, and cell shape through cytoskeletal tension,
controlled the lineage commitment 60. The MSCs‟ fate has also been directed by the elasticity of
the matrix resembling the specific tissue environment 61. Hickman‟s group has previously
demonstrated how physical as well as chemical cues control the function of endothelial and
neuronal cells. In these studies, chemically defined surfaces and media were used to direct cell
adhesion, proliferation, spreading and differentiation62-66.
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Figure 10. Schematic Illustration of the Role of Cell Shape and Cytoskeletal Tension in the
Differentiation of MSCs.
When an uncommitted mesenchymal stem cell is plated on either a small (left) or large (right)
island of fibronectin (blue lines), the consequent effect on cell shape, Rho GTPase activity, and
cytoskeletal tension regulates the commitment to either the adipogenic or osteogenic lineage 67.

1.6. Differentiation of Human MLPCs from Umbilical Cord into Glia
In this study it was investigated whether the control of environmental conditions could induce
differentiation of human adult stem cells into glia. Adult stem cells were utilized because they
provide many advantages over fetal or embryonic stem cells. Adult stem cells are relatively
abundant and easy to isolate. Furthermore, they are less likely to be rejected and do not appear to
cause tumors after transplantation. Finally, there are no ethical considerations in harvesting adult
stem cells. The adult stem cells in this study were human umbilical cord stem cells (hMLPCs).
14

The first goal of the study was to determine the effect of soluble environmental factors on
differentiation of umbilical cord stem cells into oligodendrocytes. The soluble factors were
represented by a number of molecules involved in stem cell differentiation or oligodendrocyte
development. The major target was NE, previously shown to be involved in both stem cell
differentiation and oligodendrocyte development 43, 46, 48, 68. NE is known to activate  and 
adrenergic receptors expressed by its target cells, resulting in activation of associated
downstream signaling pathways. The soluble factors alone in the standard 2D conditions were
able to induce differentiation of hMLPCs along the initial stages of oligodendrocyte lineage.
The next goal was to investigate the effect of surface chemistry and geometry on differentiation
of hMLPCs into oligodendrocytes. Previously published studies indicated that surface chemistry
and geometry influenced stem and progenitor cell differentiation. For example, MSCs on large
fibronectin islands differentiated into osteoblasts, while MSCs on small islands differentiated
into adipocytes60. However, the effect of surface chemistry and geometry on the glial
differentiation of adult stem cells was not known. In order to recreate the right in vivo
environment, with biology and engineering interacting at multiple levels, a novel 3D
environment was constructed which guided differentiation of hMLPCs from umbilical cord into
oligodendrocytes. The 3D environment was constructed from two sandwiched coverslips. The
limited space between coverslips provided a defined environment within which cells resided and
differentiated as well as provided surface cues to the top and bottom of the cells. All parameters
were known and controllable. In the 3D environment, hMLPCs developed into oligodendrocytes
and expressed the mature oligodendrocyte marker MBP. To facilitate oligodendrocyte functional
assembly and to promote myelination in vitro, hMLPCs were co-cultured with rat embryonic
15

hippocampal neurons (EHNs). To examine whether the structural dimensions of the axon and the
expression of membrane-bound axonal signals could provide sufficient physical cues for
differentiation, the co-culture was performed in 2D and 3D culture conditions. The results
indicated that after growth factor removal, hMLPCs developed into terminally differentiated
oligodendrocytes in both 2D and 3D and wrapped their processes around the axons. To date,
oligodendrocytes have been produced mostly from embryonic or fetal stem cells by other
researchers. Differentiation of hMLPCs in vitro could generate an unlimited numbers of
oligodendrocytes for studies of various differentiation stages or for transplantation to treat
demyelinating diseases.
Finally, similar methodology was examined to determine if astrocytes could be differentiated
from hMLPCs. It is known that oligodendrocytes and type 2 astrocytes develop from a common
bi-potential progenitor28, 30, 69. Astrocytes have been generated mostly from neural or embryonic
stem cells by activation of several sets of ligands and receptors. For example, it has been shown
that bone morphogenetic factors (BMPs) increase the percentage of astrocytes from neural stem
cells while decreasing the production of neurons and oligodendrocytes70, 71. Differentiation to
astrocyte fate has been also accomplished by increased activity of leukemia inhibitory factor
(LIF), basic FGF (bFGF), Notch signaling or with ciliary neurotrophic factor (CNTF)70, 72-81. It
has been demonstrated that CNTF caused transient commitment of O2-A progenitors toward a
type 2 astrocyte fate73, 82. A stable astrocyte fate has been achieved only in the presence of
extracellular matrix-associated molecules, confirming the significance of environmental cues
during cell differentiation and fate commitment. However, there are no published studies using
NE to differentiate stem cells into astrocytes. In this study, astrocyte fate was achieved only in

16

the presence of physical cues provided by rat embryonic hippocampal neurons.

After the

induction of hMLPCs differentiation by NE and by physical contact with neurons, human
astrocytes were separated from rat neurons by a density gradient and cultured further as a pure
human astrocyte population. These results enable human astrocytes generated from the umbilical
stem cells to be readily obtained and it would overcome many ethical issues associated with the
use of embryonic or fetal stem cells.

17

2. MATERIALS AND METHODS

2.1. Modification of Surfaces
Glass coverslips (18x18mm2, VWR,) were cleaned using HCl/methanol (1:1), soaked in
concentrated H2SO4 for 2 hrs and then rinsed in double deionized H2O. Coverslips were then
boiled in deionized water, dried with nitrogen and cured at 110 °C in an oven. The
trimethoxysilylpropyldiethylenetriamine (DETA, United Chemical Technologies), tridecafluoro1,1,2,2-tetrahydroctyl- 1-trichlorosilane (13F, Gelest) and poly(ethylene glycol) (PEG, Sigma
Chemical Co., St. Louis, MO) monolayers were formed by the reaction of the cleaned surfaces
with a 0.1% (v/v) mixture of the organosilane in toluene (Fisher T2904). The DETA coverslips
were heated to just below the boiling point of toluene for 30 min, and then rinsed with toluene,
reheated to just below the boiling temperature, and then oven dried. Surfaces were characterized
by contact angle and X-ray photoelectron spectroscopy methods as described previously83.

2.2 Patterns Preparation
DETA/13F or DETA/PEG SAMs patterns were utilized in order to determine interaction on
single cell level. These patterns consist of a co-planar monolayer of non-permissive and
permissive regions: 13 F or PEG are the non-permissive, cytophobic regions of the DETA/13F or
DETA/PEG SAMs patterns, respectively, while DETA monolayer is the permissive, cytophilic
region of the SAMs patterns in both cases. Different approaches have been undertaken in order
18

to prepare the 2 types of SAMs patterns: the DETA/13F SAMs patterns were made by first
patterning the DETA monolayer followed by a 13F backfill, while the DETA/13F SAMs patterns
were made by patterning the PEG monolayer followed by a DETA backfill. The SAMs of DETA
or PEG were patterned using a deep UV (193 nm) excimer laser (Lambda Physik) at a pulse
power of about 200 mJ and a frequency of 10 Hz for 45 seconds through a quartz photomask
(Bandwidth Foundry, Eveleigh, Australia). The photomasks used in the patterning process
differed also, depending on the type of SAMs patterns prepared, DETA/13F or DETA/PEG,
respectively: a “positive” photomask consisting of chromium patterns on a transparent, quartz
background (DETA/13F SAMs patterns), and a “negative” photomask consisting of transparent
patterns on chromium background (DETA/PEG SAMs patterns). The energy dosage (8-15 J/cm2)
was sufficient to ablate the regions of the SAMs monolayer exposed to the UV light, and yield
reactive hydroxyl groups. The irradiated surfaces (DETA-derivatized SAMs or PEG- derivatized
SAMs) were subsequently rederivatized with 13F, or DETA, respectively. The rederivatization
with 13F was done in an inert atmosphere by the reaction of the irradiated surfaces with a 0.1 %
(v/v) solution of 13F (Gelest, SIT8174.0) in dry chloroform (Sigma Aldrich, cat# 439142) for 5
min. The rederivatization with DETA was done as described above, but at lower temperature,
60°C.

2.3. Contact Angle Measurements
Water contact angle measurements were measured with a Ramé-hart goniometer (Mountain
Lakes, NJ). The contact angle of a static sessile drop (5µl) of water was measured three times
and averaged.
19

2.4. X-Ray Photoelectron Spectroscopy
The XPS characterization of DETA and PEG-silane surfaces was done with a Thermo
ESCALAB 220i-XL X-Ray photoelectron spectrometer equipped with an aluminium anode and
a quartz monochromator. The surface charge compensation was achieved by using a low-energy
electron flood gun. Survey scans were recorded in order to determine the relevant elements (pass
energy of 50 eV, step size= 1 eV). High resolution spectra were recorded for Si 2p, C 1s, N 1s,
and O 1s (pass energy of 20 eV, step size= 0.1 eV).
The spectrometer was calibrated against the reference binding energies of clean Cu, Ag and Au
samples. In addition, the calibration of the binding energy (BE) scale was made by setting the C
1s BE of carbon in a hydrocarbon environment at 285 eV. N 1s and Si 2p peak deconvolution
was performed with Avantage version 3.25 software, provided by Thermo Electron Corporation.
Water contact angle on DETA was 48 +/-2. Water contact angle on PEG was 37 +/-2.
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MS060410_batch1
DETA_XPS analyzes

N 1s/Si2p x 5000 = 1575
Contact angle = 48-50

1575

Figure 11. XPS Analysis of a DETA modified of Glass Coverslip.
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2.5. hMLPCs Cell Culture
hMLPCs, human umbilical cord blood-derived clonal cell lines, passage 5, were purchased from
BioE Inc., St. Paul, MN. The cells were cultured in tissue-culture treated T-75 flasks and
maintained in growth medium, Dulbecco‟s Modified Eagle Media–high glucose (DMEM, Gibco
BRL, Rockville, MD), with the addition of 15% fetal bovine serum (Stem Cell Technologies,
Vancouver, BC) and 1% Antibiotic Antimycotic (Gibco BRL) at 37°C in humidified atmosphere
containing 5% CO2. The medium was changed every 3-4 days. Cells were passaged by
trypsinization (0.05% trypsin/EDTA solution; Gibco BRL) upon reaching 60% confluence and
replated at a 1:3 ratio. Passage 8 was used for the experiments unless otherwise indicated.

2.6. EHNs Cell Culture
All applied procedures were approved by the Institutional Animal Care and Use Committee of
UCF. The protocol was modified from previously published work for embryonic rat
hippocampal cultures65, 66, 84-86. Pregnant rats, 18 days in gestation obtained from Charles River,
were euthanized with carbon dioxide and the fetuses were collected in ice cold Hibernate E
(BrainBits)/B27/GlutamaxTM/Antibiotic-Antimycotic (Invitrogen) (dissecting medium). Each
fetus was decapitated and the whole brain was transferred to fresh ice cold dissecting medium.
After isolation, the hippocampi were collected in a fresh tube of dissecting medium.
Hippocampal neurons were obtained by triturating the tissue using a Pasteur pipette. In order to
remove any debris from damaged cells the 1 ml cell suspension was layered over a 4 ml step
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gradient (Optipep diluted 0.505: 0.495 (v/v) with the dissecting medium and then made to 15%,
20%, 25% and 35% (v/v) in the dissecting medium) followed by centrifugation for 15 min at 800
g and 40C. After centrifugation, one strong band of cells was obtained. This band of cells was
resuspended in culture medium (Neurobasal/B27/GlutamaxTM/Antibiotic-Antimycotic) and
plated at a density of 100 cells/mm2 on DETA coated coverslips or at a density of 75 cells/mm2
on line pattern coverslips.

2.7. Induction of Oligodendrocyte Differentiation
hMLPC were seeded on DETA-coated glass coverslips (18 mm) at a density of 4x103 cells/cm2
in growth medium. After 3 days, at 60% confluence, the cells were incubated for 24 hours in
pre-induction medium, consisting of DMEM, 15% FBS, bFGF, EGF (10 ng/ml each, R & D
Systems, Minneapolis, MN) and PDGF-AA (10 ng/ml, Chemicon International, Temecula, CA).
Pre-induction medium for neuronal differentiation was composed of DMEM, 15% FBS and
bFGF (20 ng/ml). To initiate differentiation, the pre-induction medium was removed, the cells
were washed 2x with Hanks' balanced salts solution (Gibco BRL) and transferred to serum free
differentiation medium. Differentiation medium was composed of DMEM, N2 supplement (1%,
Gibco BRL), 10 µM forskolin, 5 U/ml heparin (Sigma, St. Louis, MO), 5 nM K252a, bFGF,
EGF, PDGF-AA (10 ng/ml each) and 20 µM NE (Sigma). The differentiation medium was
changed every other day, while NE was added daily. For agonist experiments, norepinephrine
was substituted with either the α1-adrenoceptor agonist isoproterenol or the β-receptor agonist
isoproterenol (20 µM each, Sigma).
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2.8. Co-cultures
EHNs were plated on DETA coated coverslips in hippocampal culture medium. After 4 days,
half of the culture medium was replaced with serum free pre-induction medium consisting of
DMEM, N2 supplement (1%, Gibco BRL), bFGF, EGF (10 ng/ml each, R & D Systems,
Minneapolis, MN) and PDGF-AA (10 ng/ml, Chemicon International, Temecula, CA). After 24
hrs, another half of the medium was replaced with pre-induction medium and hMLPCs were
plated on the top of the EHNs at cell density 5x103 cells/cm2. After 24 hrs, half of the preinduction medium was replaced with differentiation medium, composed of DMEM, N2
supplement (1%, Gibco BRL), 10 µM forskolin, 5 U/ml heparin (Sigma, St. Louis, MO), 5 nM
K252a, 20 µM NE (Sigma), and with or without bFGF, EGF, PDGF-AA (10 ng/ml each). 24 hrs
later, another half of the differentiation medium was replaced. After this medium replacement,
half of the differentiation medium was changed every other day, while NE was added daily.

2.9. Construction of 3D Environment
hMLPCs were plated on DETA-coated glass coverslips (18 mm) in growth medium. At 60%
confluence, growth medium was replaced with pre-induction medium. After the medium
replacement, another set of coverslips was placed on the top of the cells. Prior to the placement,
the top coverslips were ethanol sterilized and washed in the pre-induction medium. After 24
hours the pre-induction medium was removed, the cells were washed 2x with Hanks' Balanced

24

Salts Solution and transferred to serum free differentiation medium. The differentiation medium
was changed every other day and NE was added daily.

2.10. Morphological Analysis
Phase-contrast images were taken with a commercial Nikon Coolpix 990 camera using the Zeiss
Axiovert S100 microscope. Pictures were analyzed using Scion Image Software (Scion Corp.,
Frederick, MD).

2.11. Immunocytochemistry
To characterize cells by immunocytochemistry, the top coverslips, if present, were first carefully
removed. Cells were then briefly washed with Hanks' balanced salts solution and fixed in 4%
paraformaldehyde for 18 min. Fixed cells were stored in PBS, permeabilized with 0.5 % Triton
100x in PBS for 7 min, blocked with 5% donkey serum for 1 hr, followed by incubation with
primary antibody overnight at 4°C. Primary antibodies were mouse monoclonal A2B5
(MAB312, 1:250), O4 (MAB345, 1:100), O1 (MAB344, 1:200), MBP (1:25), rabbit polyclonal
anti-galactocerebroside (AB142, 1:200), Anti-Nuclei (HuNu), (MAB1281, 1:1000), Anti-Glial
Fibrillary Acidic Protein (GFAP), (AB5804,1:2000), all from Chemicon, mouse monoclonal
beta-2-AR (sc-81577, 1:200), rabbit polyclonal beta-1AR (sc-567, 1:250,) from Santa Cruz
Biotechnology, alpha-1-AR (ab3462, 1:1000) and Neuron specific beta III Tubulin (ab18207,
1:250) both from Abcam Inc., Cambridge, MA. Following a PBS washing, cells were incubated
with an Alexa Fluor 488-conjugated anti-mouse IgG or Alexa Fluor 488-conjugated anti-rabbit
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IgG for 2 hours at room temperature. After a PBS washing, the coverslips were mounted with
Vectashield mounting medium (H1000, Vector Laboratories, Burlingame, CA) onto slides. For
general visualization of cellular nuclei, the specimens were counterstained with DAPI.
Immunoreactivity was observed and analyzed by using an Ultra VIEW™LCI confocal imaging
system (Perkin Elmer).

2.12 Isolation of Astrocytes by Discontinuous Percoll Gradients
For discontinuous Percoll gradients, 3 ml of 60% Percoll were added to the bottom of a 15-ml
conical tube. Another 2 ml of 30% Percoll were slowly overlaid such that there was a sharp
separation between the two concentrations. Without disturbing the gradient interfaces, the
gradients were overlaid with 1 ml of the cell suspension. The gradients were transferred to a
centrifuge and spun 10 min at 150 × g, at 4°C. The astrocyte-enriched fraction migrated to the
buffer/30% Percoll interface, and the neuron-enriched fraction migrated to the 30%/60%
interface. The astrocyte enriched layer was carefully aspirated. The cell suspension was
transferred into a fresh 15-ml conical tube, containing 10 ml DMEM medium, high glucose, and
centrifuged 10 min at 150 × g, at 4°C. Pelleted cells were resuspended in differentiation medium
and plated on DETA coated coverslips.
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2.13. Quantification
The morphological and immunocytochemical quantification was performed on undifferentiated
stem cells or cells during various differentiation stages. For each coverslip, at least 10 pictures
were taken from randomly chosen views under 200x magnification. All the marker-positive cells
were counted, as well as the total number of cells in these views. At least three coverslips in each
group were quantified and data were expressed as average ± standard deviation (SD). Statistical
differences between different experimental groups were analyzed by Student‟s t-test.
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3. RESULTS

3.1 Acquisition of Neuronal Morphology
Motoneurons and oligodendrocyte are sequentially generated from a ventral population of
neuroepithelial stem cells during development of the CNS25, 87. Previous studies demonstrated
involvement of NE in the differentiation of oligodendrocytes from oligodendrocyte precursors 37,
48

. Other findings illustrated the influence of NE on development of spinal motoneurons and

functional maturation of spinal cord43-45. However, the effect of NE on the generation of
oligodendrocytes or motoneurons from stem cells is not known. Therefore, the influence of NE
on differentiation of hMLPCs into motoneurons was investigated. Differentiation of stem cells
along motoneuron or oligodendrocyte lineage is controlled by distinct molecular mechanisms
influenced by various factors such as PDGF-AA, bFGF, EGF and changes in intracellular cAMP
levels. These factors along with NE were employed to differentiate hMLPCs in a defined, serum
free culture system. First, hMLPCs were plated on trimethoxy-silylpropyl-diethylenetriamine
(DETA)-coated coverslips and allowed to evenly spread and expanded either for 3 days or to
60% confluence. At 60% confluence, the culture medium was replaced with the pre-induction
medium supplemented with bFGF. After 24 hrs, cells were transferred into the differentiation
medium.

Differentiation medium contained the growth factors bFGF, EGF and PDGF-AA

along with K252a, heparin, forskolin and NE. To determine the optimal dosage of NE, hMLPCs
were treated with different NE concentrations, ranging from 10-500 M. Cells treated with 100500 M concentrations of NE exhibited radical morphological changes within the first 4 hrs. Cell

28

bodies become smaller and round with the long process like extensions, resembling the
morphology of neurons (Figure 12). However, in the continuous presence of NE, cells did not
survive past 72 hrs. Thus, after 4hrs, once cells assumed neuronal morphology, differentiation
medium was replaced with one deficient in NE. Once in differentiation medium lacking NE,
cells retained their neuron like morphology for 72 hrs.

Figure 12. Phase Images of hMLPCs Treated with 100 M NE for 4 hrs.
(A) hMLPCs exhibit neuron like morphology at 4 hrs after treatment with 100 M NE. (B)
Higher magnification image showing neuron like morphology of treated cells. (C) Untreated
hMLPCs exhibit fibroblast morphology. (D) hMLPCs regained their fibroblast morphology 4
days after NE removal. Scale bars 100 m.
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Table 1. Percentage of Cells Exhibiting Neuron-like Morphology in Response to NE.

3.2. Transient Expression of Neuronal Markers
In order to characterize these neuron like cells, immunocytochemical analysis was performed for
expression of neuronal markers at 17, 36 and 72 hrs post induction (Figure 13). First, cells were
stained for expression of nestin, known to be expressed by neural stem cells and progenitor cells.
Results indicated that at 17 hrs post-induction 28.9±4.1% of the cells expressed nestin. But after
36 hrs post induction all nestin expression was lost, suggesting the cells could progress to a more
differentiated stage. Staining with neuronal marker IIIT revealed positive staining in 49.5±3.7%
of cells 17 hrs post induction and in 13.3±4.8% of cells 36 hrs post induction. These cells also
expressed motoneuron marker transcription factor Hb9, 87.2±12.5% at 17 hrs and 94.2±3.3% at
36 hrs post induction. However, 72 hrs after the treatment, the expression of neuronal markers
diminished, the cells slowly flattened and regained their fibroblastic morphology.
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Figure 13. Transient Expression of Motoneuron Markers 17 hrs after Treatment with 100 M
NE.
(A) hMLPCs transiently expressed nestin, IIIT and Hb9 after the treatment. (B) Higher
magnification images showing co-expression of nestin and IIIT. All scale bars 100 m. (C)
Expression of neuronal markers 17 and 36 hrs after treatment. Error bars represent the SD.
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To examine the effect of low dosages of NE on differentiation of hMLPCs, the cells were treated
with 10, 20, 30 and 50 M of NE daily (Table 2). Treatment with 10 M NE did not induce any
significant morphological changes within the first 2 weeks of treatment. Treatment with 30 M
resulted in increased cell death and treatment with 50 M resulted in cell death within the first
week. However, when cells were treated with 20 M of NE daily, 67.1±7.7% of cells slowly
contracted and developed multiple processes, resembling immature oligodendrocyte precursors,
within 8 days of treatment.
Table 2. Percentage of Cells Exhibiting Oligodendroglial Morphology in Response to NE.
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3.3. hMLPCs and Oligodendrocytes May Share Neuroepithelial Origin
Oligodendrocytes and motoneurons arise from the Sox1 positive neuroepithelium during
development. Induction of oligodendrocyte fate is characterized by expression of A2B5 and
PDGFR-α30, 88. In order to explore whether untreated hMLPCs could have some neuroepithelial
or oligodendrocyte progenitor characteristics, immunocytochemical analysis for expression of
Sox1, A2B5 and PDGFR-α was performed. The results indicated that untreated hMLPCs were
Sox1 positive. This suggested that hMLPCs, like oligodendrocytes, originate from the
neuroepithelium. Untreated cells were PDGFR-α positive and A2B5 negative but expressed
PDGFR-β (Figure 14). The negative expression of A2B5 and positive staining for PDGFR-β
distinguished the untreated hMLPCs from oligodendrocyte progenitor cells. These results are
interesting when compared to recently published findings demonstrating that Sox1+
neuroepithelium also gives rise to the first wave of multipotent MSCs, generated during prenatal
development89, 90.
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Figure 14. Immunocytochemical Analysis of Untreated hMLPC Suggest Neuroepithelial Origin.
Untreated hMLPCs expressed the neuroepithelial marker Sox-1, stained positively for PDGFR-α,
PDGFR-β and negatively for A2B5. Scale bar, 100 µm, (20x magnification).
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3.4. Differentiation of hMLPCs in a 2D Environment
The development to an oligodendrocyte phenotype is influenced by factors such as PDGF-AA,
bFGF, EGF and changes in intracellular cAMP levels. Based on these mechanisms, hMLPCs
were induced to differentiate into the initial stages of the oligodendrocyte lineage in a defined,
serum free culture system. Prior to differentiation, the hMLPCs were plated on DETA-coated
coverslips and allowed to evenly spread and expanded either for 3 days or to 60% confluence. It
was observed that higher cell densities reduced the differentiation efficiency, whereas low cell
density negatively affected the survival. When the cells were 60% confluent, the culture medium
was replaced with the pre-induction medium supplemented with bFGF, EGF and PDGF-AA.
After 24 hrs, cells were transferred into the differentiation medium.

Differentiation medium

contained the growth factors bFGF, EGF and PDGF-AA along with K252a, heparin, forskolin
and NE. The essential differentiation factors were NE, forskolin and K252a, as the desired
morphology was not observed in the absence of any of these factors (Figures 15B, 15C, 15D).
Both forskolin and K252a are factors frequently used during different stages of stem cell
differentiation; however norepinephrine emerged as the novel stem cell differentiation factor that
uniquely promoted the hMLPCs along an oligodendrocyte lineage. Absence of the growth
factors increased the differentiation rate but resulted in decreased survival and less elaborate
process formation (Figure 15E). After the transfer into the differentiation medium, the hMLPCs
exhibited cell shape changes, from that of a fibroblast morphology (Figure 15A) to refractile cell
bodies. Within 8 days of differentiation, approximately 70% of cells developed multiple
processes and Figures 15F, 15G and 15H reflect the morphology development at day 15. During
the process, a close correlation between the passage number and the differentiation potential was
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observed. The most favorable outcome for differentiation of the hMLPCs was found when
utilizing cells from passage 8. Earlier passages did not respond as well to the treatment and
retained higher proliferation rates. Later passages exhibited a somewhat decreased differentiation
capacity and a propensity towards senescence.
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Figure 15. Phase Contrast Images of Differentiating hMLPCs in 2D Environment.
Undifferentiated (Und) hMLPCs exhibited fibroblast morphology. Cells at 15 days in
differentiation medium without NE, forskolin (-For) or K252a retained their fibroblast
morphology. Process formation was visible in the medium without growth factors (-PEF).
Refractile cell bodies and increased process formation were observed in the presence of all
factors indicated above (+All). Cells lost their multipolar morphology and became bipolar or
spindle shaped at day 24. Scale bars, 100 µm, (first two rows 20x magnification, third row 40x
magnification (+All) and 20x magnification (D24)).
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Immunocytochemical analysis was performed using the antibodies for specific stages of
oligodendrocyte differentiation (Figures 16A, 16B). The untreated hMLPCs showed negative
staining for A2B5 and faint staining for O4. Cells were also negative for the more mature
oligodendrocyte markers O1 galactocerebroside and MBP. However, at 8 days of differentiation,
72.4 ± 3.4% of cells exhibited positive staining for A2B5 and 69.9 ± 4.9% for O4, but expression
of O1 galactocerebroside and MBP was absent at this time period in the 2D environment. The
results indicated that in response to the treatment, the majority of hMLPCs acquired cellular
characteristics of immature oligodendrocyte precursor cells. The expression of A2B5 and O4,
accompanied by a multi-process morphology, persisted to day 15, but the precursors did not
achieve a fully differentiated oligodendrocyte phenotype. After 15 days of differentiation, cells
began to lose their multi-process morphology and became mostly bipolar and spindle shaped
(Figure 15I). At day 20, 35.0 ± 4.8% of cells remained A2B5 positive, 49.7 ± 7.9% O4 positive
and O1, MBP negative (Figure 16B). In addition, limited cell survival was observed after day 20
in culture.
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Figure 16. 2D Environment Promotes Differentiation of hMLPCs along Early Stages of
Oligodendroglial Lineage.
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(a) Immunocytochemical analysis of differentiating hMLPC in 2D environment. The untreated
hMLPCs showed negative staining for A2B5 and faint staining for O4. At 15 days of
differentiation, cells exhibited positive staining for A2B5 and O4, characteristics of immature
oligodendrocyte precursor cells. (b) hMLPCs do not Differentiate into Committed
Oligodendrocytes in a 2D Environment. At 8 days of differentiation, 72.4% of cells were
positive for A2B5 and 69.9% for O4 and at day 15 70.3% of the hMLPCs exhibited positive
staining for A2B5 and 69.7% for O4. At 20 days, 35.0% of cells remained A2B5 positive and
49.7% O4 positive. Expression of O1 galactocerebroside and MBP was absent in both untreated
and differentiating cells. Scale bar, 100 µm, (Rows 1 and 2, 20x magnification and Row 3, 40x
magnification). Error bars represent the SD.
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3.5. Differentiation of hMLPCs in a 3D Environment
Because it has been shown to be an important feature of cellular development, the effect of a
simple 3D environment was examined on oligodendrocyte lineage progression. To construct this
3D environment, cells were differentiated between 2 coverslips. Initially, undifferentiated cells
were plated onto DETA-coated coverslips at the bottom of 12-well plates. When the cells
reached 60% confluence, the culture medium was replaced with the pre-induction medium, then,
after the medium replacement, an unmodified glass coverslip was placed over the top of the
cultured cells. In the 3D environment, within 24 hrs significant cell morphological flattening and
spreading was observed (Figure 17B). After 24 hrs, the pre-induction medium was replaced with
differentiation medium and there was a further increase in cell flattening (Figure 17C) but within
10 days of differentiation cells began to form processes and the cell bodies slowly contracted.
Process development and branching continued for 3 weeks. After 30 days of differentiation,
approximately 85% of the cells had elaborated an extensive network of processes (Figures 17D,
17E, 17F). The presence of PDGF was required for process formation, as in its absence cells
progressed through initial differentiation stages but lost their multi-process morphology after 2
weeks of differentiation. The presence of bFGF and EGF was not essential but resulted in
increased branching and the development of highly elaborated processes (Figures 17G, 17H,
17I).
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Figure 17. 3D Environment Promotes Further Differentiation of hMLPCs.
(A-F) Phase contrast images of differentiating hMLPCs. (A) The untreated cells displayed
typical fibroblast morphology. (B) Cells exhibited flattening and spreading at 24 hrs in 3D
environment. (C) Cells at 8 days in the differentiation medium displayed increased flattening. (D,
E, F) At 30 days of differentiation, approximately 80% of cells revealed extensive processes. (GI) Growth factors influenced the development of processes. (G, H) Immunostained cells
displaying increased branching and development of processes in presence of bFGF and EGF. (I)
Simple processes were observed in absence bFGF and EGF.
magnification).
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Scale bars, 100 µm, (40x

Immunocytochemical analysis revealed that after 20 days of differentiation 81.8 ± 6.6% of the
cells expressed the oligodendroglial marker A2B5 and 80.6 ± 2.9% O4 (Figure 18C). At 30 days
of differentiation, 57.7 ± 3.6% of the cells stained positively for A2B5, 79.6 ± 2.9% for O4, 42.1
± 2.7% for the committed oligodendrocyte marker O1 galactocerebroside and 15.2 ± 0.5% for
MBP (Figures 18A, 18B, 18C). The 3D environment appeared to play a key role during
differentiation, oligodendrocyte commitment and lineage progression. There was decreased cell
proliferation and, unlike in the 2D environment, passage numbers did not significantly affect
differentiation in the 3D environment. Even after the removal of NE from the differentiation
medium after 20 days, the cells retained their differentiated morphology for an additional 10
days in culture.
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Figure 18. hMLPCs Differentiate into Committed Oligodendrocytes in a 3D Environment.
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(A) Immunocytochemical analysis of differentiating hMLPCs in a 3D environment. The
untreated hMLPCs indicated negative staining for A2B5, faint staining for O4 and negative
staining for O1 galactocerebroside and MBP. At 30 days of differentiation, cells exhibited
intensely positive staining for A2B5 and O4. Cells also expressed O1 galactocerebroside and
MBP, characteristic of committed oligodendrocytes. Scale bars, 100 µm, (Rows 1-7, 200x
magnification and Rows 4-5, 400x magnification). (B) Co-expression of O4 and
galactocerebroside (GC) in the differentiated cells. At 30 days of differentiation, GC was
expressed in O4 positive cells. Scale bars, 100 m, (Row 1, 200x magnification and Row 2, 400x
magnification). (C) The progression of differentiation in a 3D environment. At 20 days of
differentiation 81.8% of cells expressed the oligodendroglial markers A2B5 and 80.6% O4 and
were negative for O1and MBP. At 30 days of differentiation, 57.7% of cells stained positively
for A2B5, 79.6% for O4, 42.1% for committed oligodendrocyte marker O1 and 15.2% for MBP.
Error bars represent the SD.
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The contribution of the surface chemistry of the top coverslip was also qualitatively investigated
as previously it has been shown that surface composition can have a dramatic effect on cellular
response and differentiation63,

64, 91

. To determine the most appropriate 3D conditions for

differentiation, the top glass coverslips were also modified with various surface chemistries
which had been found previously to selectively promote or repel cell adhesion (Table 3).
Unmodified glass coverslips were used as a control. To promote cell adhesion, the top coverslip
was coated with a DETA monolayer. This environment, in which cells were attached to both top
and bottom coverslips, produced initially good differentiation but eventually caused increased
cell death, possibly due to damage from cell movement during feeding and morphological
evaluation as the cells were well adhered to both surfaces. For the inverse situation the top
coverslip was coated with polyethyleneglycol (PEG) or with a non-adhesive fluorinated silane
(13F) monolayer. The PEG coated top coverslips resulted in good cell survival but a lesser
degree of differentiation. 13F coated coverslips (contact angle >100º) triggered significant cell
death. Thus it was determined that the glass coverslips controls were the most suitable top
surfaces for optimal differentiation, as the cells did not adhere to the glass, and remained on the
bottom DETA coated coverslips even after the top coverslip was removed.
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Table 3. Percentage of Cells Developing Processes in Response to Surface Modification.

Data show mean ± SD for three coverslips at day 20 and 30 of differentiation.
** No surviving cells were observed at day 30.
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3.6. hMLPCs Express Functional ARs in the 3D System
To investigate the role of adrenergic signaling mechanisms in oligodendrocyte differentiation
from the hMLPCs, immunocytochemical analysis was performed for expression of α- and βARs. The findings indicated that hMLPCs already expressed β1-ARs on the cell surface before
differentiation (Figure 19A). No expression of β2-ARs before or during differentiation was
detected. Expression of α1-ARs was first observed at the nucleus and the intensity of staining
significantly increased after treatment with pre-induction medium supplemented with bFGF,
EGF and PDGF-AA (Figure 19B). Further analysis revealed that bFGF alone was able to
increase nuclear expression of α1-ARs (Figure 19C) in a time and dose dependent manner
(results not shown). At day 15 of differentiation the α1-ARs began to relocate to the cell surface.
At day 30, differentiated cells expressed α1-ARs at the surface of cell bodies and to a lesser
degree in the processes (Figure 19B). This surface expression was observed only in cells with a
multi-process morphology, whereas in cells exhibiting a flat morphology, or undifferentiated
cells, the α1-ARs remained at the nucleus. These studies are consistent with recent findings
demonstrating nuclear localization of α1-AR92, 93. The published studies provided a new model
for α1-AR signaling, in which a signal is transduced from the nucleus to the plasma membrane,
and is confirmed in this cellular transformation as well. The same initial expression patterns were
noted in the 2D system, but the cells were not viable past day 20.
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Figure 19. Expression of α1- and β1-ARs.
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(a) Positive staining for β1-ARs in undifferentiated cells, cells pre-induced for 24 hrs with bFGF,
EGF and PDGF-AA, and cells at 30 days of differentiation. Scale bar, 100 µm. (b) Nuclear
expression of α1-ARs in undifferentiated cells, intensive nuclear staining in cells pre-induced for
24 hrs with bFGF, EGF and PDGF-AA, and surface expression at 30 days of differentiation. (c)
Nuclear expression of α1-ARs in undifferentiated cells and evidence of a significant increase in
staining intensity after 24 hrs treatment with bFGF alone. Scale bars, 100 m, (40x
magnification).
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3.7. Activation of Both α- and β-AR is Essential for Differentiation in the 3D System
To assess the role of each adrenergic receptor in the differentiation process, NE was substituted
in the differentiation medium with equimolar concentrations of the β-AR agonist isoproterenol,
the α1-AR agonist phenylephrine or with both agonists. Daily treatment with isoproterenol
induced morphological changes, cell body contraction and formation of processes within the first
15 days of treatment. However, approximately 60% of the cells displayed a bipolar morphology
resembling immature oligodendrocyte progenitors. Cells did not change their bipolar
morphology within 30 days of differentiation (Figure 20C) and exhibited enhanced cell death. In
order to characterize these cells, immunocytochemical analysis at day 30 of differentiation was
done. It was observed that 57.9 ± 4.9% of the cells expressed A2B5 and 42.5 ± 2.7% O4,
however the cells were O1 and MBP negative (Figure 20G). These results demonstrated that
stimulation of β-AR by isoproterenol induced the initial stages of differentiation. However, β-AR
treatment alone was not sufficient to direct the MLP cells into a more mature stage of
differentiation.
Daily treatment of the hMLPCs with the α1-AR agonist phenylephrine initially resulted in only
modest effects. Good cell survival was observed but the majority of cells maintained a flat
morphology. Within 15 days of differentiation approximately 40% of the cells began to develop
processes, however at day 30, only 15% of the cells exhibited more mature morphology with
developed processes. The majority of cells showed only partial process development and
branching or maintained a flat morphology (Figure 20D). Immunocytochemical analysis at day
30 revealed that 40.5 ± 3.4% of cells stained positively for A2B5, 39.8 ± 2.8% for O4 and 15.2 ±
1.5% for O1 (Figure 20G). The results suggested that activation of α1-AR could play a role in
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more advanced stages of differentiation in which cells start to lose expression of A2B5 and begin
to express O1.
Daily treatments of cells with both isoproterenol and phenylephrine resulted in formation of
multiple processes and the treated cells became morphologically similar to those treated with NE
(Figures 20A and 20B). At day 30 of the differentiation period, 48.7 ± 4.9% of the cells stained
positively for A2B5, 50.2 ± 1.1% for O4, 28.9 ± 5.2% for O1 and 9.7 ± 0.7% for MBP (Figures
20F, 20G).
The results indicate that stimulation of both the α- and β-ARs is required for optimal
differentiation. This suggests a close interplay between both ARs, ultimately resulting in the
expression of genes essential for oligodendrocyte development.
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Figure 20. Influence of ARs on Differentiation of hMLPCs into Oligodendrocytes.
(a) Phase contrast images of cells at 30 days of differentiation, in the presence of NE, exhibited a
complex multipolar morphology (A). Cells differentiated for 30 days in the medium where NE
was substituted by the β-AR agonist isoproterenol and the α1-AR agonist phenylephrine (B).
Cells were morphologically comparable to cells treated with NE. Cells differentiated in the
presence of the β-AR agonist isoproterenol frequently displayed bipolar morphology, resembling
immature oligodendrocyte progenitors (C). Substitution of NE by the α1-AR agonist
phenylephrine resulted in mature morphology in 10% of the cells. The remainder of the cells
showed only partial process development or remained flat (D). Cells differentiated for 30 days
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without activation of ARs by NE or AR-agonists continued to exhibit a mostly flat morphology
(E). (b) Stimulation of both α1- and β1-ARs is required for optimal differentiation.
Immunocytochemical analysis of cells differentiated for 30 days in the presence of β-AR agonist
isoproterenol and the α1-AR agonist phenylephrine. Cells stained positively for A2B5, O4, O1
and MBP. Scale bars, 100 µm. (c) Comparison of differentiation levels achieved by activation of
both ARs by NE, by both AR agonists (Iso+Phen), by β-AR by isoproterenol (Iso) and by α1-AR
agonist phenylephrine (Phen). Error bars represent the SD.
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3.8. Co-culture of hMLPC with EHNs
The engineered 3D culture environment provided essential physical cues to guide differentiation
of hMLPCs into MBP positive oligodendrocytes. To facilitate their functional assembly and to
promote myelination in vitro, hMLPCs were co-cultured with rat EHNs. It had been previously
shown that differentiation of oligodendrocyte precursors is controlled by the spatial and
geometric characteristics of an axonal niche59. To examine whether the structural dimensions of
the axon and the expression of membrane-bound axonal signals could provide sufficient physical
cues for differentiation, the co-culture was performed in 2D and 3D culture conditions. To
observe the interaction on single cell level, the cells were plated on DETA line patterns,
separated by a cell repellent 13F coating.

First, rat EHCs were plated on the coverslips

containing the line patterns in hippocampal culture medium. After 4 days, half of the culture
medium was replaced with serum free pre-induction medium. After 24 hrs, another half of the
medium was replaced with pre-induction medium. 24 hrs later, hMLPCs were plated on the top
of EHNs. 24 hrs later, half of the pre-induction medium was replaced with differentiation
medium, composed of DMEM, N2 supplement, forskolin, heparin, K252a, NE and with or
without growth factors: PDGF-AA, EGF and bFGF (PEF). 24 hrs later, another half of the
differentiation medium was replaced. After this medium replacement, half of the differentiation
medium was changed every other day, while NE was added daily. While the morphology of
EHNs remained unchanged, significant changes were detected in morphology of the hMLPCs.
Within first 48 hrs of co-culture, the cells contracted and developed rounded cell bodies with
multiple processes (Figure 21). 3D cultures did not perform well as the cells adhered to both
coverslips and it caused much cell death or were not noticeably different from the 2D conditions.
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Figure 21. Morphological Changes of hMLPCs at 48 hrs after the Co-culture.
(A) Untreated hMLPCs before the co-culture exhibit fibroblast morphology. (B) Typical
morphology of EHNs. (C) Rounded cell bodies and multiple processes of hMLPCs after the coculture. Scale bars 100 m.
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As cells continued to differentiate, a morphological difference was observed related to the
presence or absence of growth factors (PEF) in the medium. The difference in cellular
morphology was markedly evident at 7 days of differentiation and became increasingly
pronounced with increased differentiation time. Figure 18 reflects the cellular morphology at day
12. In the presence of growth factors in the medium, cells rapidly proliferated, spread, grew in
size and developed long processes. Without the growth factors, cells remained smaller and in
close contact with surrounding cells. A high proliferation rate was not observed, possibly due to
a lack of growth factors and cellular contact inhibition. With increasing differentiation time, the
distance between cells became shorter and after 3 weeks of co-culture, cells became so compact
one could not clearly distinguish their morphology. These morphological changes were observed
only in hMLPCs in physical contact with neurons. hMLPCs localized in the areas of low
neuronal density, without physical contact with neurons, remained spindle shaped or flat. This
suggests that physical cues provided only by axons were essential for differentiation in this
system.
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Figure 22. Phase Contrast Images of hMLPCs Co-cultured with EHNs.
(A) EHNs alone. Co-culture of hMLPCs and EHNs at 12 days of differentiation (B) in the
absence of growth factors, (C) in the presence of growth factors. Higher magnification images
of the co-culture differentiated (D-F) in the presence of growth factors and (G-I) in the absence
of growth factors. Scale bars 100 m.
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3.9. Differentiating Human Oligodendrocytes can be distinguished from Rat Neurons
Differentiating hMLPCs were identified by immunocytochemistry using a monoclonal antibody
against human specific nuclear antigen (HuNu). This antibody does not react with nuclei from
rat. Rat EHNs were detected by employing neuron specific beta IIIT antibody. Untreated
hMLPCs did not express neuronal IIIT, and HuNu immunostaining revealed their large nuclei.
When hMLPCs were co-cultured with EHNs and induced to differentiate, approximately 70%
cells significantly contracted and reduced in size. The same was true for changes of nuclear
morphology. As cells continued to differentiate, their nuclei became rounded and substantially
smaller. No significant changes were observed in the morphology of IIIT stained neurons.
Immunocytochemical analysis of the co-culture at day 12 revealed that in presence of growth
factors 66.8±5.8 % of the cells stained positive for HuNu and 40.4±5.5% of the cells stained
positive for IIIT. In absence of growth factors, 48.8±3.1% of the cells expressed HuNu and
55.6±3.3% expressed IIIT. The results of both conditions indicated that the human derived
differentiating oligodendrocytes can be distinguished from rat neurons in this system.
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Figure 23. Immunocytochemical Analysis Distinguished hMLPCs from Rat EHNs.
(A) hMLPCs stained positively for human specific HuNu and negatively for IIIT. EHNs did not
stain for HuNu but expressed the neuronal marker IIIT. The hMLPC and EHN co-culture at
day 12 of differentiation showed positive staining for both HuNu and IIIT. Scale bars 100 m.
(B) hMLPCs alone stained 100% positively for HuNu and were negative for IIIT. EHNs alone
stained 100% positively for IIIT but did not express HuNu. Co-culture at day 12 in the
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differentiation medium containing PEF revealed that 66.8±5.8% of the cells stained positively
for HuNu and 40.4±5.5% cells stained positively for IIIT. In absence of PEF, 48.8±3.1% of the
cells expressed HuNu and 55.6±3.3% expressed IIIT. Error bars represent the SD.
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3.10. hMLPCs Differentiate into Mature Oligodendrocytes in the Presence of EHNs
Differentiated cells were identified by immunocytochemical analysis for expression of
oligodendroglial markers (Figure 24A). Results revealed that at 14 days of differentiation, in the
presence of growth factors, 48.9±6.2% of the co-cultured hMLPCs expressed the bipotential
oligodendrocyte/astrocyte progenitor marker A2B5 and 17.1±3.4% of cells expressed the early
oligodendroglial marker O4 (Figures 24A and B). It was observed that the O4 positive cells were
localized exclusively in the areas of highest cell density. Cells were negative for O1 and MBP.
However, 39.3±4.6% of the co-cultured cells stained positively for the astrocyte marker glial
fibrillary acidic protein (GFAP). These cells progressively exhibited long and sparsely branched
processes, typical of type II astrocytes (Figure 24A). Some of the GFAP positive cells reached
sizes up to 200 m. These results suggested that in presence of growth factors, oligodendroglial
differentiation of hMLPCs was arrested at the A2B5/O4 stage. It appeared that growth factors
influenced the fate choice of proliferating bipotential A2B5 progenitors to become GFAP
positive astrocytes. In absence of growth factors 44.2±5.3% of the cells stained positively for
A2B5, 55.6± 3.3% for O4, 20.2± 1.9% for the committed oligodendrocyte marker O1 and
11.9±4.2% for MBP (Figures 24A and B).

The O4, O1 and MBP positive cells were

concentrated in the most cell dense regions. The results indicated that after growth factor
removal, hMLPCs developed into terminally differentiated oligodendrocytes. These findings are
consistent with previously published studies describing oligodendrocyte generation from A2B5
positive progenitors36,

94-96

. In these studies the progression from progenitor to myelinating

oligodendrocyte entails a sequence of events, initiated by withdrawal of PDGF-AA and bFGF
growth factors. This contributed to cell cycle withdrawal and cytoskeletal changes. In the
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presence of neurons, terminally differentiated oligodendrocytes then wrapped their processes
around the axons to initiate myelination.
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Figure 24. Immunocytochemical Analysis of Co-cultures Differentiated for 14 Days.
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(A) In the absence of PEF, differentiated hMLPCs expressed the early and late oligodendrocyte
markers A2B5, O4, O1 and MBP. In the presence of PEF cells did not progress into mature
oligodendrocytes. Scale bars 100 m. (B) In the presence of PEF, 48.9±6.2% of the co-cultured
cells expressed the bipotential glial progenitor marker A2B5 and 17.1± 3.4% the marker O4 and
were negative for O1 and MBP. In absence of PEF, 44.2±5.3% of the cells stained positively for
A2B5, 55.6± 3.3% for O4, 20.2± 1.9% for the committed oligodendrocyte marker O1 and
11.9±4.2% for MBP. Error bars represent the SD.
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3.11. Differentiated Oligodendrocytes Wrap around Axons in Culture
The primary function of oligodendrocytes is to produce the myelin sheath, which insulates axons
of the CNS and facilitates rapid saltatory conduction of action potentials. To investigate whether
the newly differentiated oligodendrocytes were functional and capable to myelinate the axons of
rat EHNs, co-cultures were examined at day 21 by immunocytochemical analysis. At day 21, in
the differentiation medium without growth factors, MBP positive oligodendrocytes exhibited
elaborate processes and acquired a typical stellate appearance. It was observed that numerous
primary processes of these cells emerged from the cell body and divided to form secondary
processes. Tertiary processes then established interconnections between primary and secondary
ones. These interconnections tended to appear first close to the cell body and then expanded
further (Figures 25C and D). In the areas with high axonal density, oligodendrocytes aligned
their processes along the length of axons and wrapped them around axonal fibers, that were
labeled with the neuronal marker IIIT (Figures 25A and B).
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Figure 25. Immunocytochemical Analysis of Mature Oligodendrocytes.
(A) Oligodendrocytes wrapping their processes around axons. Scale bar 100 m. (B) Mature
oligodendrocytes wrapped around an axon. Scale bar 50 m. (C-D) Morphology of mature
oligodendrocytes. Scale bars 50 m.
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3.12 Generation of Pure Astrocyte Population
In order to generate a pure astrocyte population, differentiated astrocytes were separated from rat
neurons using a density gradient. For this purpose, cells were trypsinized of the culture surface at
day 5 of co-culture and passed through a Percoll gradient. The small neurons passed through the
30% Percoll and come to rest on a cushion of 60% Percoll. The larger, membranous astrocytes
stopped at the medium/30% Percoll interface.

Figure 26. Percoll Gradient Separation of Astrocytes97.
Isolated astrocytes were than replated on DETA coated coverslips and cultured further in the
differentiation medium. After 5 days, immunocytochemical analysis was performed for the
astrocyte markers GFAP and S100 and for the human specific markers HuNu and human
microtubule marker.
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The results indicated a pure human derived astrocyte population (Fig.27)

Figure 27. Immunocytochemistry of Astrocytes Isolated by Percoll Gradient.
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4. DISCUSSION

Motoneurons, oligodendrocytes and astrocytes are produced during CNS development from a
restricted domain of the ventral ventricular zone, termed the pMN domain98.

These cells

sequentially arise from Sox-1 positive neuroepithelial cells of the neural tube16-18. In this study,
functional oligodendrocytes were generated from Sox-1 positive hMLPCs from human umbilical
cord. It is possible that hMLPCs, like cells of the CNS and early waves of multipotent MSCs,
originate from neuroepithelium during development 89,

90

. hMLPCs from umbilical cord are

collected at birth and have the potential to give rise to all three embryonic layers 99. This study
has indicated that hMLPCs display extreme sensitivity to their environment. Their fate depends
not only on soluble factors but also on the surrounding physical cues. The combination of these
external signals, processed through signal transduction networks, altered the cell morphology,
induced transitional expression of motoneuron markers and finally, influenced fate decision to
differentiate along the oligodendrocyte linage. Various published findings have illustrated the
influence for NE on development of spinal motoneurons and the functional maturation of spinal
cord43-45. For example, it was illustrated that noradrenergic innervations of the ventral horn
rapidly peaks during development of the spinal cord and then declines at the end of neonatal life
to the values found in the young adult. The rapid increase of NE levels during prenatal
development suggests a significant role for NE in the differentiation of motoneurons. In other
studies, electron microscopy images have provided evidence for direct noradrenergic control of
oligodendroglial and astroglial cells throughout the cortex48. Oligodendrocytes were the major
target of the noradrenergic fibers, exhibiting a light thickening at the sites of contact. It was
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reported that oligodendrocytes expressed α1 and β-ARs and their activation by NE accelerated
differentiation of the oligodendrocyte precursors37, 49, 51. In spite of this, there were no known
studies using NE as a key factor to induce differentiation of stem cells into oligodendrocytes. To
explore this possibility, hMLPCs were analyzed for expression of ARs, and it was found that the
undifferentiated cells expressed both α1-ARs and β1-ARs. The β1-ARs were localized on the
surface before and during the differentiation. Surprisingly, typical surface expression of the α1ARs was not observed; instead, the α1-ARs were localized at the nucleus. The intensity of
nuclear staining significantly increased after treatment with bFGF. However, as the cells
exhibited a more differentiated phenotype after 15 days of differentiation and then relocation of
α1-ARs to the surface was observed. Nuclear localization of α1-ARs is consistent with a recently
proposed model for α1-AR signaling in cardiac myocytes. In this new model, activation of α1AR signaling is initiated at the nuclear membrane and results in localization of activated ERK in
calveolae at the plasma membrane92, 93.
Differentiation was initiated by the transfer of hMLPCs into the differentiation medium in a 2D
environment. The differentiation medium contained NE along with forskolin, K252a, heparin,
PDGF-AA, bFGF and EGF. Within 8 days in the differentiation medium, process formation was
observed and immunocytochemical analysis indicated a positive reactivity to A2B5 and O4
primary antibodies. In spite of this, cells did not progress further along the oligodendrocyte
lineage. After 2 weeks in differentiation medium, cells exhibited bipolar and spindle like
morphology and remained A2B5 and O4 positive, but O1 negative, and prolonged differentiation
time also significantly increased cell death.
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A 3D microenvironment was constructed to combine chemical and physical cues shown to
influence lineage commitment during development in other systems. The hMLPCs
responded to the 3D environment initially by cell flattening and later, within 2 weeks of
differentiation, formation of processes. At 30 days, 42.1 ± 2.7% of cells expressed the O1
antigen, indicating terminally differentiated oligodendrocytes, and 15.2 ± 0.5% of the cells
expressed MBP with increased cell survival. The differentiated cells survived for more than 40
days in culture. Importantly, the oligodendrocytes retained their differentiated state even after
removal of the NE after 20 days.
It is well established in other systems that after removing growth factors from the medium,
oligodendrocyte precursors exit cell cycle, stop dividing and terminally differentiate

100-102

. In

our system, more complex branching, process development and increased survival was
demonstrated in the presence of growth factors. This could be explained by the combined effect
of forskolin and norepinephrine. Both factors are known to increase cAMP levels, and increased
cAMP levels inhibit proliferation of oligodendrocyte precursors37,
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. Thus, the removal of

growth factors was not essential for cell cycle exit and terminal differentiation. Decreased
proliferation with increased cell flattening and spreading was also observed after the introduction
of the top coverslip.
It has also been demonstrated previously that stimulation of β-ARs induces differentiation
through an increase in intracellular cAMP and through the activation of proteins known to be
involved in cell cycle arrest 37. There are also studies revealing that p38MAPK and Erk1/2 have
roles in differentiation of oligodendrocyte progenitors104. Both ARs can activate p38MAPK
while Erk1/2 is a downstream target of α1-AR. It was shown in these studies that p38MAPK
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activity was required for the progression of bipolar early progenitors (A2B5+, O4-) to multipolar
late progenitors (O4+, O1-), and Erk1/2 activity was essential for progression of late progenitors
to oligodendrocytes36.
Our results indicated that the majority of cells treated with the β-AR agonist isoproterenol
remained bipolar even after 30 days of differentiation. Immunocytochemical analysis indicated
differentiation arrest at the stage where A2B5+ cells began to express O4, perhaps due to
insufficient activation of Erk1/2 signaling. In contrast, cells treated with the α1-AR agonist
phenylephrine showed higher survival and after 30 days of differentiation 15.2 ± 1.5% of cells
had progressed to the O1+ stage, possibly due to increased stimulation of the Erk1/2 signaling
pathway. However, simultaneous activation of both receptors by NE, or by both agonists, was
the best strategy, possibly by supplying the optimal cAMP levels and stimulating essential
signaling pathways engaged in the close interplay during differentiation. This study
demonstrated the significance of cellular microenvironment as a driving force in human stem cell
differentiation. A 3D environment was constructed and a novel small molecule was utilized to
induce differentiation of hMLPCs, whereas neither condition alone produced functional
differentiation. The mechanical cues in combination with soluble factors influenced the
progression of hMLPCs along the oligodendrocyte lineage.
To investigate whether hMLPCs‟ derived human oligodendrocytes are functional and capable to
myelinate axons, hMLPCs were co-cultured with rat EHNs. Because axons could also provide
physical cues to influence functional differentiation, the co-culture was performed in 2D as well
as 3D conditions. Our results indicated that structural dimensions of the axons and the expression
of membrane-bound axonal signals provided sufficient physical cues for differentiation in 2D
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conditions. In co-culture, hMLPCs differentiated into mature oligodendrocytes or astrocytes
based on presence/absence of growth factors in differentiation medium. In the absence of PDGFAA, EGF and bFGF, hMLPCs differentiated into oligodendrocytes.
At day 21, in the differentiation medium, MBP positive oligodendrocytes exhibited elaborate
processes and acquired a typical stellate appearance. The formation of elaborate processes was
observed and in the areas with high axonal density, oligodendrocytes aligned their processes
along the length of axons and wrapped them around the rat axonal fibers, as revealed by
immunocytochemical analysis at day 21.
In the presence of PDFGF-AA, EGF and bFGF, hMLPCs differentiated into astrocytes and
stained positively for astrocyte markers GFAP and S100, and for human markers HuNu and
human specific microtubule marker. These results support a sequential model for motoneuronglia differentiation, in which astrocytes are generated in sequential order from proliferating stem
cells, after establishment of motoneurons and oligodendrocytes. It is well known that PDGF-AA,
EGF and bFGF have a positive effect on stem cell proliferation. Thus, increased proliferation
time could be one of the key factors responsible for astrocyte fate in this system.

The

responsiveness of differentiating astrocytes to NE was expected. Both astrocytes and
oligodendrocytes are contacted by noradrenergic synaptic terminals and astrocytes, like
oligodendrocytes, express alpha and beta adrenergic receptors.
To generate a pure population of human astrocytes, cells were separated from neurons utilizing a
Percoll density gradient. After the separation, the cells were replated to produce a homogenous
culture and the differentiated astrocytes exhibited large rounded cell bodies with long processes,
morphologically resembling protoplasmic astrocytes. Cells were surprisingly large in size, some
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reaching over 200 m. These observations could be explained by previously published findings
indicating that human protoplasmic astrocytes are approximately 2.6 times larger than their
rodent counterparts6, 11.
These studies demonstrated for the first time methods for obtaining human oligodendrocytes and
astrocytes in high yield from human umbilical cord stem cells in defined and controllable
environmental conditions. Alternative differentiation into oligodendrocytes or astrocytes was
achieved entirely by environmental control. Furthermore, unlike other studies employing sonic
hedgehog signaling, NE was utilized as a novel differentiation molecule and noradrenergic
signaling as a novel route to attain a glial fate from adult stem cells.
Human umbilical cord stem cells are a highly promising source of cells for tissue regeneration105.
Compared to adult stem cells obtained from bone marrow, these cells are immature and elicit a
lower incidence of graft rejection, graft-versus-host disease and low post transplant infections105.
Besides this biological superiority, these stem cells are abundantly available and routinely
harvested without risk to the donor 106. Compared to embryonic stem cells, obtained from human
embryos, human umbilical cord stem cells are not only easily obtainable, but also could be more
suitable for cellular therapeutics. Embryonic stem cells have been associated with reports of the
uncontrollable development of teratomas in a syngeneic transplantation model, imprintingrelated developmental abnormalities and ethical issues. Human umbilical cord stem cells, readily
available and differentiated by environmental signals, offer an added potential therapeutic
advantage. These cells can be used as a source of cells for cellular therapeutics at this particularly
tenuous time for embryonic stem cell research, after a federal ruling that undercut government
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funding for many initiatives in the field, including Geron Corporation. Human cells obtained
from umbilical cord can represent the next wave: living cells as therapeutics.
Future studies will expand understanding of the role of the microenvironmental signals and
noradrenergic signaling in the glial differentiation. Terminally differentiated functional human
oligodendrocytes and astrocytes will be generated for use in in vivo studies to develop treatment
for conditions such as multiple sclerosis, neuropathy and traumatic brain injury.
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